IL6 and ovarian carcinoma: Cohen et al. have demonstrated that IL6 inhibition in cisplatin induced overexpressing ovarian cancer cells resulted into significant sensitization to cisplatin, suggesting IL-6 involvement in the induction of platinum resistance [38].